Physician profile
Jeffrey Kramer
NPI 1124056486
$2,608.02
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,151 · 2020: $366 · 2021: $91.76.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $1,191.42 | 2019-2020 | |
| Lilly USA, LLC | $262.82 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $167.89 | 2019 | |
| Novartis Pharmaceuticals Corporation | $130.76 | 2019-2020 | |
| Allergan, INC. | $98.33 | 2019-2020 | |
| Genentech USA, INC. | $94.40 | 2019 | |
| Alexion Pharmaceuticals, INC. | $77.74 | 2019 | |
| Mdd US Operations, LLC | $70.98 | 2019 | |
| Genzyme Corporation | $69.21 | 2019-2020 | |
| Ucb, INC. | $60.95 | 2019-2020 | |
| Adamas Pharmaceuticals, INC. | $44.62 | 2019 | |
| Emd Serono, INC. | $42.77 | 2019 | |
| Acadia Pharmaceuticals INC | $38.09 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $36.76 | 2019 | |
| Abbvie INC. | $36.43 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $31.90 | 2021 | |
| Amgen INC. | $27.87 | 2019-2020 | |
| Boston Scientific Corporation | $24.23 | 2019 | |
| Celgene Corporation | $23.43 | 2021 | |
| Jazz Pharmaceuticals INC. | $19.25 | 2020 | |
| Amneal Pharmaceuticals LLC | $17.13 | 2019 | |
| Chiesi USA, INC. | $16.57 | 2019 | |
| Acorda Therapeutics, INC | $12.80 | 2019 | |
| Merck Sharp & Dohme LLC | $11.67 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Kramer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.